Abstract | PURPOSE: The effects of leukotriene (LT) B4 and its receptor antagonist LY293111 on proliferation and apoptosis of human pancreatic cancer cells were investigated, both in vitro and in vivo. EXPERIMENTAL DESIGN: RESULTS: Both LTB4 receptor types were found to be expressed in human pancreatic cancer cells. The LTB4 receptor antagonist LY293111 caused both time- and concentration-dependent inhibition of proliferation of all six human pancreatic cancer cell lines studied. In contrast, LTB4 stimulated proliferation of these cell lines and induced ERK1/2 phosphorylation. The growth-stimulatory effect and ERK1/2 phosphorylation induced by LTB4 were inhibited by LY293111. Coincident with growth inhibition, LY293111 induced apoptosis in these pancreatic cancer cell lines, as indicated by morphology, TUNEL assay, and poly(ADP-ribose) polymerase cleavage. In studies using AsPC-1 and HPAC cell xenografts in athymic mice, LY293111 treatment markedly inhibited tumor growth over a 24-day treatment period, as measured by both tumor volume and tumor weight. In situ tissue TUNEL assay showed massive apoptosis in LY293111-treated tumor tissues. CONCLUSIONS:
LTB4 can directly regulate the growth of human pancreatic cancer cells and control their survival. Additional studies will clarify the underlying mechanisms of LTB4-regulated pancreatic cancer cell growth and apoptosis. LTB4 receptor blockade and inhibition of the downstream signal pathway are likely to be valuable for the treatment of human pancreatic cancer.
|
Authors | Wei-Gang Tong, Xian-Zhong Ding, Rene Hennig, Richard C Witt, Jens Standop, Parviz M Pour, Thomas E Adrian |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 8
Issue 10
Pg. 3232-42
(Oct 2002)
ISSN: 1078-0432 [Print] United States |
PMID | 12374694
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Benzoates
- LY 293111
- Receptors, Leukotriene B4
- Leukotriene B4
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Benzoates
(pharmacology)
- Blotting, Western
- Cell Division
(drug effects)
- Female
- Humans
- In Situ Nick-End Labeling
- In Vitro Techniques
- Leukotriene B4
(pharmacology)
- Mice
- Mice, Inbred BALB C
- Microscopy, Polarization
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases
(metabolism)
- Neoplasm Transplantation
- Neoplasms, Experimental
- Pancreatic Neoplasms
(metabolism, pathology)
- Receptors, Leukotriene B4
(antagonists & inhibitors, genetics, metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction
(drug effects)
- Tumor Cells, Cultured
|